Rensing Adam J, Whittam Benjamin M, Szymanski Konrad M, Bennett William E
Division of Pediatric Urology, Department of Urology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
Division of Pediatric Urology, Department of Urology, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
J Robot Surg. 2023 Feb;17(1):185-189. doi: 10.1007/s11701-022-01411-y. Epub 2022 Apr 29.
Robotic-assisted pyeloplasty (RAP) is a mainstay in the treatment of ureteropelvic junction obstruction (UPJO) in children. At our institution, to limit planned operating rooms visits we have placed a ureteral stent with an external string (SWES) immediately prior to RAP. In this study, we sought to quantify the operative time, complications, and costs associated with this approach compared to the traditional approach, requiring subsequent stent removal in the operating room. We hypothesized the SWES cohort would have decreased cost, yet with similar operative time and complications. We retrospectively collected all RAPs performed at our institution using the SWES approach (Aug 2012-July 2017). We excluded those with a redo pyeloplasty, and/or a percutaneous nephrostomy tube for post-operative drainage. We collected 30-day costs linked to the patients' MRN using the Pediatric Health Information System (PHIS) database. We compared 30-day healthare costs for all patients following RAP. We compared our SWES group to a national cohort of all pediatric RAP during the same time period. Lastly, we sent an anonymous, electronic survey to urologists of all PHIS institutions to identify the predominant postoperative drainage, nationally. Within our institution, we reviewed all those treated with SWES (n = 85) (Table 1). The median 30-day cost was $10,548 among those with SWES (Table 2). This was significantly less than the overall, national cohort of all pediatric RAP during the same period ($14,119, p < 0.001). There was a 15.5 % rate of unplanned return to the hospital in the SWES group. Of those unplanned returns, 8.2 % (7/85) had unplanned return for a procedure (3 for unplanned stent removal, 2 for nephrostomy tube for persistent obstruction, 1 for omental hernia, and 1 for stent replacement). With a 42.5 % (37/87) response rate, our nationwide survey found 84.6 % primarily leave stents WITHOUT a string, 7.7 % left nephrostomy tubes, and 7.7 % stents with strings. During pediatric RAP, placement of a SWES takes little time, carries a risk of unplanned visit to the operating room, saves the patient a certain, second anesthetic for stent removal, and amounts to a cost savings of approximately 25 %.
机器人辅助肾盂成形术(RAP)是治疗儿童肾盂输尿管连接部梗阻(UPJO)的主要方法。在我们机构,为减少计划中的手术室就诊次数,我们在RAP手术前立即放置了带有外部牵引线的输尿管支架(SWES)。在本研究中,我们试图量化与这种方法相关的手术时间、并发症和成本,并与传统方法(需要在手术室后续取出支架)进行比较。我们假设使用SWES的队列成本会降低,但手术时间和并发症相似。我们回顾性收集了在我们机构采用SWES方法进行的所有RAP手术(2012年8月至2017年7月)。我们排除了那些进行过再次肾盂成形术和/或用于术后引流的经皮肾造瘘管的病例。我们使用儿科健康信息系统(PHIS)数据库收集了与患者医疗记录号相关的30天成本。我们比较了所有接受RAP手术患者的30天医疗成本。我们将我们的SWES组与同期全国所有儿科RAP队列进行了比较。最后,我们向所有PHIS机构的泌尿科医生发送了一份匿名电子调查问卷,以确定全国范围内主要的术后引流方式。在我们机构内,我们回顾了所有接受SWES治疗的患者(n = 85)(表1)。使用SWES的患者中,30天成本中位数为10,548美元(表2)。这显著低于同期所有儿科RAP的全国总体队列(14,119美元,p < 0.001)。SWES组计划外重返医院的发生率为15.5%。在那些计划外重返医院的患者中,8.2%(7/85)是因手术而计划外重返(3例因计划外取出支架,2例因肾造瘘管用于持续性梗阻,1例因网膜疝,1例因更换支架)。我们的全国性调查回复率为42.5%(37/87),结果发现84.6%的人主要留置不带牵引线的支架,7.7%留置肾造瘘管,7.7%留置带牵引线的支架。在儿科RAP手术中,放置SWES花费时间少,存在计划外手术室就诊风险,为患者节省了一次取出支架的麻醉,并节省了约25%的成本。